Carolinas Medical Center Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 83
• Ovarian cancer diagnosis and treatment 79
• Uterine Myomas and Treatments 21
• PI3K/AKT/mTOR signaling in cancer 17
• Cervical Cancer and HPV Research 14
• Protein Degradation and Inhibitors 14
• Monoclonal and Polyclonal Antibodies Research 9
• COVID-19 and healthcare impacts 8
• Acute Lymphoblastic Leukemia research 6
• Cancer, Hypoxia, and Metabolism 6
• Cancer Immunotherapy and Biomarkers 5
• Diversity and Career in Medicine 5

Most cited

1. Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

   Journal for immunotherapy of cancer · 2022 · 271 citations · Jubilee Brown

2. Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.

   JAMA network open · 2023 · 120 citations · Jubilee Brown

3. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.

   The Lancet. Oncology · 2024 · 61 citations · Wendel Naumann

4. Low-grade serous ovarian cancer: expert consensus report on the state of the science.

   International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023 · 70 citations · Jubilee Brown

5. Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

   Clinical cancer research : an official journal of the American Association for Cancer Research · 2023 · 75 citations · Jubilee Brown

6. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer.